PatientsForce named a preferred supplier for PSP program management
AI-translated from the Chinese original · editorially reviewed
In Taiwan, a new drug often faces a long wait between obtaining marketing approval and gaining reimbursement, leaving a growing number of patients facing the challenge of self-funded treatment. Since 2015, PatientsForce has been committed to providing these patients with comprehensive support, partnering with leading pharmaceutical companies to help patients obtain the treatments they need and ease their financial burden.
PatientsForce, Media-WIND Health Strategies, MediCloud Biotech, and other companies have been recognized as preferred Patient Support Program (PSP) suppliers by leading companies including Pfizer, becoming an important long-term partner for international pharmaceutical companies in delivering PSP services.
Outstanding compliance and sustainability earn the trust of international pharmaceutical companies
PatientsForce takes seriously the high demands international pharmaceutical companies place on compliance, sustainability, and information security in their global supply chain management. In operations management and risk control, it has strengthened its management systems to ensure conformity with standards such as quality and drug safety, so as to reduce potential risks and enhance the value of collaboration.
International certifications, quality assurance:
ISO 9001: Quality management system, ensuring service stability and standardized processes.
ISO 27001: Information security management system, safeguarding confidential data and compliance risk management.
ISO 27701: Privacy information management system, meeting privacy protection requirements such as GDPR.
While pursuing service excellence, PatientsForce also actively practices ESG corporate social responsibility and has passed high-scoring assessments:
ESG corporate social responsibility, sustainable development:
EcoVadis certification: Measures a company's performance across environment, labor, human rights, ethics, and sustainable procurement.
SBTi SMEs 2030 Net-Zero commitment: Pledging to achieve science-based emissions reduction targets by 2030, in line with global sustainable supply chain trends.
PatientsForce's value and commitment
As a long-term partner of international pharmaceutical companies, PatientsForce ensures greater market value in regulation, risk management, and sustainable operations, offering partners the following core advantages:
1. Reducing operational and regulatory risk
Conforming to international certification standards to ensure data security and privacy compliance.
2. Enhancing ESG supply chain value
Holding international ESG certifications, demonstrating a commitment to sustainable operations.
3. Ensuring stable long-term collaboration
A sound governance and risk management framework to ensure uninterrupted service.
Scalable services, continuing to work for greater patient welfare
PatientsForce continuously transforms through digital technology to provide scalable services and to build a healthcare support ecosystem, improving service efficiency—especially by offering more comprehensive support for self-funded patients—so that more patients can gain access to more medical resources.